By multivariate analysis NEDD9 and p38 protein expression levels and various clinicopathological features (gender, stage, grade, number of tumors, and regional lymph node involvement) were independent prognostic parameters of bladder cancer patients' outcome (Table 4). The gene discussed is MAPK14; the disease is urinary bladder carcinoma.